Fonming Ltd.
豐洺有限公司
中文

Patient-centred, innovation-drivenWorking to become a provider that improves how treatment is delivered

Founded in January 2025, Fonming is a biotechnology start-up focused on the research, development and application of surgical spray devices and microneedle patch technology. With an experienced technical team and a commitment to quality and innovation, we concentrate on the design, development and manufacture of medical devices, delivering optimised solutions for unmet clinical and therapeutic needs.

Laparoscopic spray delivery system

In gynecological minimally invasive surgery, anti-adhesion gel has to cover the surgical field evenly within a confined working space. Applying it with existing instruments is slow and coverage is hard to judge, which makes it a burden in the surgical workflow. This system uses gas-driven distributed output so that application becomes fast and predictable.

  • Applicable procedures: multiple uterine cyst and severe adhesiolysis surgery
  • Compatible with minimally invasive surgery
  • Plug and use — shorter application time

Dissolving microneedle patch platform

The bottleneck in microneedle patch production is not the formulation but the mold. Conventional mold development is expensive and the process cycle is long, which makes small-batch, high-variety development impractical. This platform addresses forming and drying, lowering the barrier to microneedle patch development substantially.

  • Shorter process time
  • Lower mold development cost
  • Small batch, high variety